We speak with Alexis McGill Johnson, president and CEO of the Planned Parenthood Federation of America and the Planned Parenthood Action Fund, about the ruling by a Trump-appointed federal judge in Texas to revoke the Food and Drug Administration approval of the abortion pill mifepristone. Shortly after the Texas ruling, a federal judge in Washington ordered the FDA to keep mifepristone on the market and maintain the status quo. The Justice Department has appealed the Texas ruling. “People will not stop seeking access to abortion,” Johnson says. “We are just making it harder for people to get the medication and the care that they need, and that is just unconscionable.”
This content originally appeared on Democracy Now! and was authored by Democracy Now!.